Whole-Body Hybrid PET with 18F-FDG in the Staging of Non-Hodgkin’s Lymphoma

Journal of Nuclear Medicine

Hitoshi Kitayama¹  Tsunehiko Nishimura¹  Yuzuru Kanakura¹  Hiroyuki Sugahara¹  Naoki Tokita¹  Hironobu Nakamura¹  Mitsuaki Tatsumi¹ 

[1] Division of Tracer Kinetics, Biomedical Research Center; Department of Hematology and Oncology; and Department of Diagnostic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan Division of Tracer Kinetics, Biomedical Research Center; Department of Hematology and Oncology; and Department of Diagnostic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan Division of Tracer Kinetics, Biomedical Research Center; Department of Hematology and Oncology; and Department of Diagnostic Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan

关键词: FDG;    hybrid PET;    dedicated PET;    CT;    non-Hodgkin’s lymphoma;   

DOI  :  

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

PET with a double-head gamma camera (hybrid PET) is a new approach to tumor imaging with 18F-FDG. This study was conducted to clarify the feasibility of whole-body FDG hybrid PET in the staging of non-Hodgkin’s lymphoma (NHL) in comparison with PET with a dedicated camera (dedicated PET) and to compare the results of both FDG studies with those of CT and 67Ga scanning as conventional imaging studies (CIS). Methods: Thirty patients with NHL were prospectively evaluated. The results of the imaging studies regarding detection of the sites involved and staging were compared with each other and with those of the reference standard based on the final overall clinical evaluation. Results: Of the total of 206 sites, whole-body FDG hybrid PET and dedicated PET detected 159 sites (77.2%) and 179 sites (86.9%), respectively. Eighteen of the 20 sites missed by hybrid PET alone consisted of lesions < 1.5 cm. Both FDG studies provided concordant staging results in all but 2 patients. CIS, on the other hand, detected 164 (79.6%) of the 206 sites, 137 of which were also detected by hybrid PET. Hybrid PET detected an additional 22 sites not found by CIS, whereas CIS detected 27 additional sites. Hybrid PET and CIS provided concordant staging results in 19 patients. Hybrid PET correctly staged NHL in 5 additional patients, whereas CIS correctly staged NHL in only 1 additional patient. Conclusion: Whole-body FDG hybrid PET appeared to be an accurate method of staging NHL. Despite its poorer image quality compared with dedicated PET, hybrid PET provided NHL staging results comparable with those of dedicated PET. Hybrid PET also yielded results comparable with those of CIS. However, whole-body FDG hybrid PET is currently inadequate as a single modality for staging NHL and is complementary to CT.

【 授权许可】

Unknown